FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2951416917> ?p ?o ?g. }

• W2951416917 endingPage "183" @default.
• W2951416917 startingPage "175" @default.
• W2951416917 abstract "Identification of the genes responsible for adult-onset type II citrullinemia (CTLN2) and citrin protein function have enhanced our understanding of citrin deficiency. Citrin deficiency is characterized by 1) neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD); 2) adaptation/compensation stage with unique food preference from childhood to adulthood; and 3) CTLN2. The treatment of NICCD aims to prevent the progression of cholestasis, and it includes medium chain triglycerides (MCT) milk and lactose-free milk, in addition to medications (e.g., vitamin K2, lipid-soluble vitamins and ursodeoxycholic acid). Spontaneous remission around the age of one is common in NICCD, though prolonged cholestasis can lead to irreversible liver failure and may require liver transplantation. The adaptation/compensation stage (after one year of age) is characterized by the various signs and symptoms such as hypoglycemia, fatty liver, easy fatigability, weight loss, and neuropsychiatric symptoms. Some poorly-controlled patients show failure to thrive and dyslipidemia caused by citrin deficiency (FTTDCD). Diet therapy is the key in the adaptation/compensation stage. Protein- and fat-rich diet with a protein: fat: carbohydrate ratio being 15–25%: 40–50%: 30–40% along with the appropriate energy intake is recommended. The use of MCT oil and sodium pyruvate is also effective. The toxicity of carbohydrate is well known in the progression to CTLN2 if the consumption is over a long term or intense. Alcohol can also trigger CTLN2. Continuous intravenous hyperalimentation with high glucose concentration needs to be avoided. Administration of Glyceol® (an osmotic agent containing glycerol and fructose) is contraindicated. Because the intense treatment such as liver transplantation may become necessary to cure CTLN2, the effective preventative treatment during the adaptation/compensation stage is very important. At present, there is no report of a case with patients reported having the onset of CTLN2 who are on the diet therapy and under the appropriate medical support during the adaptation/compensation stage." @default.
• W2951416917 created "2019-06-27" @default.
• W2951416917 creator A5000744089 @default.
• W2951416917 creator A5054121299 @default.
• W2951416917 creator A5071867145 @default.
• W2951416917 creator A5089155121 @default.
• W2951416917 date "2019-07-01" @default.
• W2951416917 modified "2023-10-03" @default.
• W2951416917 title "Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2" @default.
• W2951416917 cites W1480625907 @default.
• W2951416917 cites W1571840153 @default.
• W2951416917 cites W1608709490 @default.
• W2951416917 cites W1916874614 @default.
• W2951416917 cites W1965399930 @default.
• W2951416917 cites W1971573364 @default.
• W2951416917 cites W1987344031 @default.
• W2951416917 cites W1988114798 @default.
• W2951416917 cites W1989710964 @default.
• W2951416917 cites W1990155145 @default.
• W2951416917 cites W1994472094 @default.
• W2951416917 cites W1998426979 @default.
• W2951416917 cites W1999409415 @default.
• W2951416917 cites W2007225204 @default.
• W2951416917 cites W2010594727 @default.
• W2951416917 cites W2012713414 @default.
• W2951416917 cites W2016844315 @default.
• W2951416917 cites W2020805608 @default.
• W2951416917 cites W2023084403 @default.
• W2951416917 cites W2023752372 @default.
• W2951416917 cites W2025126642 @default.
• W2951416917 cites W2026964203 @default.
• W2951416917 cites W2029763798 @default.
• W2951416917 cites W2029879208 @default.
• W2951416917 cites W2035280267 @default.
• W2951416917 cites W2039040958 @default.
• W2951416917 cites W2043524132 @default.
• W2951416917 cites W2044541853 @default.
• W2951416917 cites W2045166056 @default.
• W2951416917 cites W2045839188 @default.
• W2951416917 cites W2051077455 @default.
• W2951416917 cites W2053253013 @default.
• W2951416917 cites W2053511737 @default.
• W2951416917 cites W2054816065 @default.
• W2951416917 cites W2072197356 @default.
• W2951416917 cites W2074095221 @default.
• W2951416917 cites W2087720223 @default.
• W2951416917 cites W2108847729 @default.
• W2951416917 cites W2121147532 @default.
• W2951416917 cites W2123858068 @default.
• W2951416917 cites W2133002620 @default.
• W2951416917 cites W2140564760 @default.
• W2951416917 cites W2142124828 @default.
• W2951416917 cites W2142311488 @default.
• W2951416917 cites W2149982642 @default.
• W2951416917 cites W2155395690 @default.
• W2951416917 cites W2164730204 @default.
• W2951416917 cites W2168362195 @default.
• W2951416917 cites W220988829 @default.
• W2951416917 cites W2333926021 @default.
• W2951416917 cites W2412415736 @default.
• W2951416917 cites W253592859 @default.
• W2951416917 cites W2549453683 @default.
• W2951416917 cites W2566280549 @default.
• W2951416917 cites W2588085272 @default.
• W2951416917 cites W2802754611 @default.
• W2951416917 cites W2913542850 @default.
• W2951416917 cites W2916537154 @default.
• W2951416917 cites W2921557829 @default.
• W2951416917 cites W354065841 @default.
• W2951416917 cites W4246251803 @default.
• W2951416917 cites W58280487 @default.
• W2951416917 doi "https://doi.org/10.1016/j.ymgme.2019.06.004" @default.
• W2951416917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31255436" @default.
• W2951416917 hasPublicationYear "2019" @default.
• W2951416917 type Work @default.
• W2951416917 sameAs 2951416917 @default.
• W2951416917 citedByCount "38" @default.
• W2951416917 countsByYear W29514169172019 @default.
• W2951416917 countsByYear W29514169172020 @default.
• W2951416917 countsByYear W29514169172021 @default.
• W2951416917 countsByYear W29514169172022 @default.
• W2951416917 countsByYear W29514169172023 @default.
• W2951416917 crossrefType "journal-article" @default.
• W2951416917 hasAuthorship W2951416917A5000744089 @default.
• W2951416917 hasAuthorship W2951416917A5054121299 @default.
• W2951416917 hasAuthorship W2951416917A5071867145 @default.
• W2951416917 hasAuthorship W2951416917A5089155121 @default.
• W2951416917 hasBestOaLocation W29514169171 @default.
• W2951416917 hasConcept C126322002 @default.
• W2951416917 hasConcept C134018914 @default.
• W2951416917 hasConcept C2776917539 @default.
• W2951416917 hasConcept C2777468819 @default.
• W2951416917 hasConcept C2777535116 @default.
• W2951416917 hasConcept C2778593092 @default.
• W2951416917 hasConcept C2778772119 @default.
• W2951416917 hasConcept C2779134260 @default.
• W2951416917 hasConcept C2779306644 @default.
• W2951416917 hasConcept C2780668416 @default.

• next